Knockdown of OLA1 inhibited HCC progression and tumorigenicity, which at the molecular level was associated with reduced G1/S-specific cyclins and increased levels of the cyclin-dependent kinase inhibitor (CKI) P21. Here, OLA1 is linked to hepatocellular carcinoma.